dihexa fda approval Dihexa Capsules 10mg (30ct) |

Discontinuation rates due to side effects reached approximately 10% across all dose levels

S., Jozic

[3] [4] [5] [6] [7] [8] [9] [10] [11] In an assay of neurotrophic activity, dihexa was found to be seven orders of magnitude more potent than brain-derived neurotrophic factor

Furthermore, when comparing the combination therapy to the standard treatment, Donepezil, the reduction in A plaque burden in both the cortex and hippocampus was similar between the groups, while the combination group showed a trend towards lower levels of soluble A

Patients interested in learning more about BPC-157 therapy can review our BPC-157 Therapy Program and our Peptide Therapy Clinic